We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

448 hedge funds and large institutions have $1.7B invested in Avanos Medical in 2015 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 107 increasing their positions, 183 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

6% more capital invested

Capital invested by funds: $1.6B → $1.7B (+$100M)

4% less funds holding

Funds holding: 468448 (-20)

15% less first-time investments, than exits

New positions opened: 75 | Existing positions closed: 88

42% less repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 183

63% less call options, than puts

Call options by funds: $2.82M | Put options by funds: $7.72M

Holders
448
Holders Change
-20
Holders Change %
-4.27%
% of All Funds
11.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
75
Increased
107
Reduced
183
Closed
88
Calls
$2.82M
Puts
$7.72M
Net Calls
-$4.9M
Net Calls Change
-$3.29M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$164M +$6.9M +149,035 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$143M +$2.35M +50,664 +2%
BIT
3
BlackRock Institutional Trust
California
$98.1M +$4.71M +101,703 +5%
RP
4
RR Partners
New York
$93.5M
SFM
5
Systematic Financial Management
New Jersey
$77.9M +$65.4M +1,411,346 +825%
State Street
6
State Street
Massachusetts
$67.2M +$322K +6,951 +0.5%
BFA
7
BlackRock Fund Advisors
California
$62.6M +$3.06M +65,981 +5%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$56.7M +$21.2M +457,722 +66%
Norges Bank
9
Norges Bank
Norway
$51M +$19M +410,033 +65%
GC
10
Greenlight Capital
New York
$35.2M -$75.9M -1,638,160 -70%
HM
11
HealthCor Management
New York
$30.5M -$15.3M -330,000 -35%
ClearBridge Investments
12
ClearBridge Investments
New York
$27M -$5.32M -114,824 -17%
RFC
13
Russell Frank Company
Washington
$26.7M +$7.82M +168,862 +45%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$25.4M -$1.01M -21,818 -4%
Northern Trust
15
Northern Trust
Illinois
$24.9M +$858K +18,532 +4%
Arrowstreet Capital
16
Arrowstreet Capital
Massachusetts
$21.6M -$7.55M -162,929 -27%
FMA
17
Fiduciary Management Associates
Illinois
$21M +$19.7M +425,979 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$20.2M +$16.4M +354,527 +643%
Bank of America
19
Bank of America
North Carolina
$19.8M -$7.38M -159,375 -28%
Citadel Advisors
20
Citadel Advisors
Florida
$19.8M +$15.2M +327,752 +437%
GAM
21
Gotham Asset Management
New York
$19.5M +$3.5M +75,651 +24%
Capital World Investors
22
Capital World Investors
California
$18.6M
PIM
23
Paradice Investment Management
Colorado
$17.4M +$16.4M +353,707 New
JP Morgan Chase
24
JP Morgan Chase
New York
$16.7M +$13.1M +282,462 +503%
Goldman Sachs
25
Goldman Sachs
New York
$16.2M +$1.5M +32,488 +11%

AVNS Hedge Fund Activity: Q1 2015 in Review

448 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2015, worth a combined $1.7B — up 6.2% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 88 funds closed out of AVNS and 75 opened new positions — a net loss of 13 holders — while 183 trimmed existing stakes and 107 added.

The largest buyer was Systematic Financial Management, adding an estimated $65.4M. The largest seller was Greenlight Capital, cutting an estimated $75.9M.

  • 448 institutional investors held Avanos Medical (AVNS) as of Q1 2015, down from 468 in Q4 2014.
  • Funds reported $1.7B of Avanos Medical stock for Q1 2015, up 6.2% quarter-over-quarter.
  • 75 funds opened new Avanos Medical positions in Q1 2015 and 88 closed out, a net change of -13 holders.
  • The largest Avanos Medical buyer in Q1 2015 was Systematic Financial Management, an estimated $65.4M added.
  • The largest Avanos Medical seller in Q1 2015 was Greenlight Capital, an estimated $75.9M sold.

Based on aggregated 13F filings for Q1 2015.